Colin Hill

Colin Hill serves as a Member of the Board of Directors for Fulcrum Therapeutics and PPD, as well as for BioTelemetry Healthcare since May 2016. Colin has held the position of CEO at Aitia since April 2010 and has been Chairman of Gene Network Sciences Inc since August 2000. Previous leadership roles include Chairman at Fina Technologies from May 2008 to July 2012. Early experience includes a summer internship at the Santa Fe Institute in 1996 and an Engineering Co-op at The Dow Chemical Company from January 1993 to June 1995. Colin holds a Master's degree in Physics from Cornell University (1997-2000) and a Bachelor of Science in Physics from Virginia Tech (1991-1996).